跳至主要内容
临床试验/CTRI/2019/04/018808
CTRI/2019/04/018808已完成未知

se of oral Tolvaptan tablet as a pre-medicant to prevent hyponatremia in patients undergoing TURP surgeries: A prospective Comparative study. - Tolvaptan in TURP

Dr Badri Prasad Das0 个研究点目标入组 84 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
84

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. All adult patients aged 50-75 yrs with good functional status with METS >4,with diagnosis of BPH posted for TURP surgery.
  • 2.Prostate size >60 gms.
  • 3.Surgeries done under monopolar cautery ( M-TURP) and irrigation fluid of 1.5% glycine.
  • 4.Baseline serum sodium level less than or equal to 132meq/lit.

排除标准

  • 1.Patients with history of allergy to study drugs.
  • 2.Uncontrolled diabetes mellitus and hypertension
  • 3.H/O Acute MI, any cardiac conditions,EF < 30 %
  • 4.Patients with cerebro vascular diseases, renal diseases and any other endocrine disorders like SIADH causing electrolyte imbalances.
  • 5.C/I for subarachnoid block
  • 7.Prostate surgery lasting less than 30 mins and more than 2 hrs

研究者

发起方
Dr Badri Prasad Das

相似试验